Marine Corps fast-tracks AI-powered ultrasounds, blood coolers to battlefield

The Marine Corps is accelerating two battlefield medical technologies: the Expeditionary Medical Refrigeration Unit, or EMRU, and the Kosmos portable ultrasound. They address different problems. The EMRU supports forward blood supplies, while Kosmos helps corpsmen look for internal injuries sooner. Together, they extend advanced care beyond established medical facilities.

The EMRU keeps blood bags cold for sustained field use and can warm blood that freezes in Arctic conditions. Kosmos gives corpsmen an AI-assisted fast ultrasound exam. Its software helps users recognize what an image may show, including a possible injury, even without years of ultrasound experience.

The push follows direct feedback from Navy surgical teams and Marine medical units. The refrigerator is planned for full Marine Corps fielding by the second quarter of 2027. Kosmos has been approved for expanded use at Role 1 units, because units told officials they wanted it immediately.

Kosmos is a portable ultrasound device that lets corpsmen conduct an AI-assisted fast exam in the field. Previously, ultrasounds were traditionally performed by Role 2 medical units, which are advanced mobile trauma units staffed by doctors. Expanded Kosmos fielding moves this capability toward Role 1 units and embedded corpsmen.

The key challenge is not placing the probe, according to Lt. Cmdr. Kyleigh Hupfl. It is understanding the image on the screen. AI support helps a less experienced operator recognize what the image shows and identify that there might be an injury. This gives basicly trained corpsmen more confidence while examining a patient.

The Marine Corps is not waiting for a slower rollout because units have said they want the device now. The plan places diagnostic support nearer to the first point of care, where corpsmen may need to decide whether continued bleeding or another injury requires evacuation.

The EMRU weighs 62 pounds, while the older blood refrigerator weighed 140 pounds. That makes the new unit 78 pounds lighter, or roughly 56 percent lighter by weight. Its compact design also requires less manpower to transport, an important advantage for distributed units operating away from established facilities.

The older unit could provide about 24 hours of refrigeration in ideal conditions. The EMRU uses rechargeable batteries and is designed to sustain the blood cold chain for longer periods. It can also warm blood if bags freeze in Arctic conditions, helping units manage blood supplies in varied environments.

The Marine Corps first rolled out the EMRU to selected units, including units sent to the Middle East. Officials reported positive feedback from medical providers there. The service now plans full operational capability across the Marine Corps, with complete fielding targeted for the second quarter of 2027 and priority for point-of-need units.

The medical cold chain is the supported movement and storage of blood at a stable cold temperature in field environments. It matters because distributed units may need their own blood supplies for longer periods before evacuation becomes possible. The EMRU is designed to bring that capability forward without relying on heavy generators.

Cold storage preserves the blood supply for field use, while the refrigerator’s warming function addresses extreme conditions. In Arctic environments, blood bags could freeze. The EMRU can warm them before use, helping prevent a patient from reaching a worse-off condition because the blood is too cold or frozen.

The goal is sustainable forward distribution, not a short-term supply at a single triage point. Units in the Middle East reported that the equipment was instrumental in maintaining a revolving blood bank. Full Marine Corps fielding is planned by the second quarter of 2027, prioritizing point-of-need units.

These devices could move important capabilities closer to Role 1 care, where smaller immediate-aid units and embedded corpsmen often see patients first. Blood refrigeration would let distributed units maintain a forward supply. Portable ultrasound would help them look for injuries rather than relying only on later evaluation at Role 2.

Role 2 medical units are advanced mobile trauma facilities staffed by doctors, and ultrasounds have traditionally been performed there. Kosmos changes that pattern by giving Role 1 corpsmen an AI-assisted fast exam. The EMRU similarly supports blood storage and distribution without depending on heavy generators.

This does not replace Role 2 treatment. Instead, it can strengthen care before evacuation and help commanders make risk decisions. Corpsmen may better assess continued bleeding, while forward units can sustain blood supplies longer. The Marine Corps is expanding Kosmos now and plans complete EMRU fielding by the second quarter of 2027.

Forward equipment matters because distributed units may have to sustain patients longer before reaching a better-equipped hospital. The article describes a shift away from relying only on the first 60 minutes, or “Golden Hour,” toward care that can continue when evacuation is delayed. Blood and diagnostic tools help keep treatment available at the point of injury.

The EMRU supports a revolving blood supply without heavy generators. Kosmos helps corpsmen examine patients and identify possible injuries, including continued bleeding. Together, the devices give medical teams more information and supplies while they wait for an evacuation opportunity.

This also supports command decisions. Hupfl said ultrasound findings can help a commander decide whether to risk an evacuation asset to get a patient out. Units in the Middle East reported that the refrigerator was instrumental to maintaining blood supplies. The Marine Corps wants both capabilities pushed as far forward as possible.

The article identifies blood loss as a central threat after battlefield injury. During the first 60 minutes, triage care and limiting hemorrhage are critical to survival odds. If evacuation is delayed, the patient still needs care that limits bleeding and keeps vital signs strong while waiting for better-equipped treatment.

The new devices support those goals in practical ways. The EMRU keeps blood available in a forward cold chain and can warm frozen blood before use. Kosmos gives corpsmen an AI-assisted ultrasound exam, helping them recognize possible injuries and assess whether bleeding may be continuing.

This supports a longer-term model of care rather than depending only on the “Golden Hour.” Hupfl said equipment should be distributed, carried by corpsmen, and logistically supported. Better forward care can help medical teams sustain a patient and help commanders decide whether an evacuation asset should be put at risk.